These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction. McLean AG; Davenport A; Cox D; Sweny P Kidney Int; 2000 Oct; 58(4):1765-72. PubMed ID: 11012911 [TBL] [Abstract][Full Text] [Related]
5. A microbiological survey of bicarbonate-based replacement circuits in continuous veno-venous hemofiltration. Moore I; Bhat R; Hoenich NA; Kilner AJ; Prabhu M; Orr KE; Kanagasundaram NS Crit Care Med; 2009 Feb; 37(2):496-500. PubMed ID: 19114901 [TBL] [Abstract][Full Text] [Related]
6. Contamination of dialysis water and dialysate. A survey of 30 centers. Bambauer R; Schauer M; Jung WK; Daum V; Vienken J ASAIO J; 1994; 40(4):1012-6. PubMed ID: 7858320 [TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813 [TBL] [Abstract][Full Text] [Related]
8. Con-Current versus Counter-Current Dialysate Flow during CVVHD. A Comparative Study for Creatinine and Urea Removal. Baldwin I; Baldwin M; Fealy N; Neri M; Garzotto F; Kim JC; Giuliani A; Basso F; Nalesso F; Brendolan A; Ronco C Blood Purif; 2016; 41(1-3):171-6. PubMed ID: 26764970 [TBL] [Abstract][Full Text] [Related]
9. Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system. Lonnemann G; Floege J; Kliem V; Brunkhorst R; Koch KM Nephrol Dial Transplant; 2000 Aug; 15(8):1189-93. PubMed ID: 10910443 [TBL] [Abstract][Full Text] [Related]
12. Bacterial contamination of hemodialysis water in three randomly selected centers in South Western Nigeria. Okunola OO; Olaitan JO Niger J Clin Pract; 2016; 19(4):491-5. PubMed ID: 27251966 [TBL] [Abstract][Full Text] [Related]
13. A fractional dialysate collection method to estimate solute removal in continuous venovenous hemodialysis. Kanagasundaram NS; Larive AB; Paganini EP Kidney Int; 2000 Dec; 58(6):2579-84. PubMed ID: 11115094 [TBL] [Abstract][Full Text] [Related]
14. Dialysate and replacement fluid composition for CRRT. Aucella F; Di Paolo S; Gesualdo L Contrib Nephrol; 2007; 156():287-96. PubMed ID: 17464138 [TBL] [Abstract][Full Text] [Related]
15. A new method of post-dialysis blood urea sampling: the 'stop dialysate flow' method. Geddes CC; Traynor J; Walbaum D; Fox JG; Mactier RA Nephrol Dial Transplant; 2000 Apr; 15(4):517-23. PubMed ID: 10727547 [TBL] [Abstract][Full Text] [Related]
16. Effects of citrate-enriched bicarbonate based dialysate on anticoagulation and dialyzer reuse in maintenance hemodialysis patients. Rocha AD; Padua VC; Oliveira E; Guimaraes MM; Lugon JR; Strogoff de Matos JP Hemodial Int; 2014 Apr; 18(2):467-72. PubMed ID: 24261328 [TBL] [Abstract][Full Text] [Related]
17. The Production, Efficacy, and Safety of Machine-Generated Bicarbonate Solution for Continuous Venovenous Hemodialysis (CVVHD): The Cleveland Clinic Method. Taliercio JJ; Nakhoul G; Vachharajani TJ; Layne M; Sedor J; Thomas G; Mehdi A; Heyka R; Demirjian S Kidney Med; 2021; 3(3):353-359.e1. PubMed ID: 34136781 [TBL] [Abstract][Full Text] [Related]
18. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability. Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115 [TBL] [Abstract][Full Text] [Related]